Initial genome sequencing and analysis of multiple myeloma
Broad Institute · Eli and Edythe Broad Foundation · +30 more institutions
Abstract
Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs. Several new and unexpected oncogenic mechanisms were suggested by the pattern of somatic mutation across the data set. These include the mutation of genes involved in protein translation (seen in nearly half of the patients), genes involved in histone methylation, and genes involved in blood coagulation. In addition, a broader than anticipated role of NF-κB signalling was indicated by mutations in 11 members of the NF-κB pathway. Of potential immediate clinical relevance, activating mutations of…
Citation impact
- FWCI
- 89.63
- Percentile
- 100%
- References
- 47
Authors
50- MAMichael A. ChapmanCorresponding
Broad Institute, Eli and Edythe Broad Foundation
- MSMichael S. Lawrence
Broad Institute, Eli and Edythe Broad Foundation
- JJJonathan J. Keats
Mayo Clinic, WinnMed, Multiple Myeloma Research Foundation, Mayo Clinic in Arizona
- KCKristian Cibulskis
Broad Institute, Eli and Edythe Broad Foundation
- CSCarrie Sougnez
Broad Institute, Eli and Edythe Broad Foundation
Topics & keywords
- Biology
- Multiple myeloma
- Gene
- Genome
- Genetics
- Massive parallel sequencing
- Mutation
- Cancer
- Good health and well-being